Citations (113)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Yuxue Wang, Yarong Wang & Jianguang Sun. (2022) The clinical effect of probiotics on patients with non-alcoholic fatty liver disease: a meta-analysis. Bioengineered 13:7-12, pages 14960-14973.
Read now
Read now
Ming Luo, Fang-Rui Hu, Rui-Juan Xin, Li Yao, Sheng-Juan Hu & Fei-Hu Bai. (2022) Altered gut microbiota is associated with sleep disturbances in patients with minimal hepatic encephalopathy caused by hepatitis B-related liver cirrhosis. Expert Review of Gastroenterology & Hepatology 16:8, pages 797-807.
Read now
Read now
Yeshimebet Kassa, Yihenew Million, Alemu Gedefie & Feleke Moges. (2021) Alteration of Gut Microbiota and Its Impact on Immune Response in Patients with Chronic HBV Infection: A Review. Infection and Drug Resistance 14, pages 2571-2578.
Read now
Read now
Linghua Yu, Linlin Wang, Huixing Yi & Xiaojun Wu. (2020) Beneficial effects of LRP6-CRISPR on prevention of alcohol-related liver injury surpassed fecal microbiota transplant in a rat model. Gut Microbes 11:4, pages 1015-1029.
Read now
Read now
Andrea Ticinesi, Claudio Tana, Antonio Nouvenne, Beatrice Prati, Fulvio Lauretani & Tiziana Meschi. (2018) Gut microbiota, cognitive frailty and dementia in older individuals: a systematic review. Clinical Interventions in Aging 13, pages 1497-1511.
Read now
Read now
Articles from other publishers (108)
Rafaela Pinto Coelho Santos, Eliana Cristina de Brito Toscano & Milene Alvarenga Rachid. (2023) Anti-inflammatory strategies for hepatic encephalopathy: preclinical studies. Arquivos de Neuro-Psiquiatria 81:07, pages 656-669.
Crossref
Crossref
Feng Zhu, Shudan Zheng, Mei Zhao, Fan Shi, Lihong Zheng & Haiqiang Wang. (2023) The regulatory role of bile acid microbiota in the progression of liver cirrhosis. Frontiers in Pharmacology 14.
Crossref
Crossref
Lucia Giuli, Marta Maestri, Francesco Santopaolo, Maurizio Pompili & Francesca Romana Ponziani. (2023) Gut Microbiota and Neuroinflammation in Acute Liver Failure and Chronic Liver Disease. Metabolites 13:6, pages 772.
Crossref
Crossref
Tonatiuh Abimael Baltazar-Díaz, Verónica Riggen-Bueno, Donovan Brandon Cortina-Romero, Susana del Toro-Arreola, Jesse Haramati, Blanca Estela Bastidas-Ramírez & Miriam Ruth Bueno-Topete. (2023) Low-diversity microbiota and an increased metabolism of arginine and aromatic amino acids: a hallmark of hepatic encephalopathy in western Mexican patients with alcohol-associated cirrhosis. Journal of Applied Microbiology 134:6.
Crossref
Crossref
Salvatore Pezzino, Maria Sofia, Chiara Mazzone, Sergio Castorina, Stefano Puleo, Martina Barchitta, Antonella Agodi, Luisa Gallo, Gaetano La Greca & Saverio Latteri. (2023) Gut Microbiome in the Progression of NAFLD, NASH and Cirrhosis, and Its Connection with Biotics: A Bibliometric Study Using Dimensions Scientific Research Database. Biology 12:5, pages 662.
Crossref
Crossref
Benjamin H. Mullish, Ege Tohumcu, Serena Porcari, Marcello Fiorani, Natalia Di Tommaso, Antonio Gasbarrini, Giovanni Cammarota, Francesca Romana Ponziani & Gianluca Ianiro. (2023) The role of faecal microbiota transplantation in chronic noncommunicable disorders. Journal of Autoimmunity, pages 103034.
Crossref
Crossref
Paula Izquierdo-Altarejos, Mar Martínez-García & Vicente Felipo. (2023) Extracellular vesicles from hyperammonemic rats induce neuroinflammation in hippocampus and impair cognition in control rats. Cellular and Molecular Life Sciences 80:4.
Crossref
Crossref
Abhishek Ghosh, Tathagata MahintamaniDevender K. RanaDebasish BasuSurendra Kumar MattooMadhumita PremkumarGeetesh Kumar Singh. (2022) Neurocognitive Functions in Patients with Comorbid Hepatitis C and Opioid Dependence: A Comparative Study. Indian Journal of Psychological Medicine 45:2, pages 146-154.
Crossref
Crossref
Yunqi SHAN, Haidan DENG, Baojun SHAN, Jiaying HUANG, Xinshu FENG & Xiaoming SUN. (2022) Motor learning dysfunction and its association with neurotransmitters and gut microbiota dysbiosis in hepatic encephalopathy mice. Journal of Holistic Integrative Pharmacy 3:4, pages 324-335.
Crossref
Crossref
Cheng Fang, Wei Lu, Qingyang Liu, Yongquan Chen, Wei Jia & Yan Xu. (2022) Comparative study between the effects of aged and fresh Chinese baijiu on gut microbiota and host metabolism. Food Bioscience 49, pages 101859.
Crossref
Crossref
Luping Wang, Bowen Sang & Zuyan Zheng. (2022) Risk of dementia or cognitive impairment in non-alcoholic fatty liver disease: A systematic review and meta-analysis. Frontiers in Aging Neuroscience 14.
Crossref
Crossref
Sung-Min Won, Ki Kwang Oh, Haripriya Gupta, Raja Ganesan, Satya Priya Sharma, Jin-Ju Jeong, Sang Jun Yoon, Min Kyo Jeong, Byeong Hyun Min, Ji Ye Hyun, Hee Jin Park, Jung A. Eom, Su Been Lee, Min Gi Cha, Goo Hyun Kwon, Mi Ran Choi, Dong Joon Kim & Ki Tae Suk. (2022) The Link between Gut Microbiota and Hepatic Encephalopathy. International Journal of Molecular Sciences 23:16, pages 8999.
Crossref
Crossref
Kai Yin, Dongxu Wang, Hongjing Zhao, Yu Wang, Yue Zhang, Yachen Liu, Baoying Li & Mingwei Xing. (2022) Polystyrene microplastics up-regulates liver glutamine and glutamate synthesis and promotes autophagy-dependent ferroptosis and apoptosis in the cerebellum through the liver-brain axis. Environmental Pollution 307, pages 119449.
Crossref
Crossref
Yang Zheng, Jiahui Wang, Jiaru Wang, Ruizhu Jiang & Tiejian Zhao. (2022) Gut microbiota combined with metabolomics reveal the mechanism of curcumol on liver fibrosis in mice. Biomedicine & Pharmacotherapy 152, pages 113204.
Crossref
Crossref
Haripriya Gupta, Sung Hun Kim, Seul Ki Kim, Sang Hak Han, Hak Cheol Kwon & Ki Tae Suk. (2022) Beneficial Shifts in Gut Microbiota by Lacticaseibacillus rhamnosus R0011 and Lactobacillus helveticus R0052 in Alcoholic Hepatitis. Microorganisms 10:7, pages 1474.
Crossref
Crossref
Menghao Li, Kai Li, Shihao Tang, Yong Lv, Qiuhe Wang, Zhengyu Wang, Bohan Luo, Jing Niu, Ying Zhu, Wengang Guo, Wei Bai, Enxin Wang, Dongdong Xia, Zhexuan Wang, Xiaomei Li, Jie Yuan, Zhanxin Yin, Jonel Trebicka & Guohong Han. (2022) Restoration of the gut microbiota is associated with a decreased risk of hepatic encephalopathy after TIPS. JHEP Reports 4:5, pages 100448.
Crossref
Crossref
Jing Liu, Dakai Yang, Xiaojing Wang, Paul Tetteh Asare, Qingwen Zhang, Lixin Na & Lei Shao. (2022) Gut Microbiota Targeted Approach in the Management of Chronic Liver Diseases. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Crossref
Hideto Kawaratani, Yasuteru Kondo, Ryoji Tatsumi, Naoto Kawabe, Norikazu Tanabe, Akira Sakamaki, Kazuo Okumoto, Yoshihito Uchida, Kei Endo, Takumi Kawaguchi, Tsunekazu Oikawa, Yoji Ishizu, Shuhei Hige, Taro Takami, Shuji Terai, Yoshiyuki Ueno, Satoshi Mochida, Yasuhiro Takikawa, Takuji Torimura, Tomokazu Matsuura, Masatoshi Ishigami, Kazuhiko Koike & Hitoshi Yoshiji. (2022) Long-Term Efficacy and Safety of Rifaximin in Japanese Patients with Hepatic Encephalopathy: A Multicenter Retrospective Study. Journal of Clinical Medicine 11:6, pages 1571.
Crossref
Crossref
Andrew C. Tolonen, Nicholas Beauchemin, Charlie Bayne, Lingyao Li, Jie Tan, Jackson Lee, Brian M. Meehan, Jeffrey Meisner, Yves Millet, Gabrielle LeBlanc, Robert Kottler, Erdmann Rapp, Chris Murphy, Peter J. Turnbaugh, Geoffrey von Maltzahn, Christopher M. Liu & Johan E. T. van Hylckama Vlieg. (2022) Synthetic glycans control gut microbiome structure and mitigate colitis in mice. Nature Communications 13:1.
Crossref
Crossref
Linna Zhao, Liji Yang, Yuying Guo, Jie Xiao, Junping Zhang & Shixin Xu. (2021) New Insights into Stroke Prevention and Treatment: Gut Microbiome. Cellular and Molecular Neurobiology 42:2, pages 455-472.
Crossref
Crossref
Cheng Fang, Qingwu Zhou, Qingyang Liu, Wei Jia & Yan Xu. (2022) Crosstalk between gut microbiota and host lipid metabolism in a mouse model of alcoholic liver injury by chronic baijiu or ethanol feeding. Food & Function 13:2, pages 596-608.
Crossref
Crossref
Luis E. DÍAZ-OROZCO & Nahum MÉNDEZ-SÁNCHEZ. (2022) Nutraceuticals and microbiota. Minerva Gastroenterology 67:4.
Crossref
Crossref
Caterina Zoratti, Rita Moretti, Lisa Rebuzzi, Irma Valeria Albergati, Antonietta Di Somma, Giuliana Decorti, Stefano Di Bella, Lory Saveria Crocè & Mauro Giuffrè. (2021) Antibiotics and Liver Cirrhosis: What the Physicians Need to Know. Antibiotics 11:1, pages 31.
Crossref
Crossref
Ziying Yuan, Shiyu Xiao, Sizhu Li, Baojun Suo, Ye Wang, Lingmei Meng, Zuojing Liu, Zhihao Yin, Yan Xue & Liya Zhou. (2021)
The impact of
Helicobacter pylori
infection, eradication therapy, and probiotics intervention on gastric microbiota in young adults
. Helicobacter 26:6.
Crossref
Crossref
Tiziano Balzano, Paola Leone, Gergana Ivaylova, M. Carmen Castro, Lestteriel Reyes, Chusé Ramón, Michele Malaguarnera, Marta Llansola & Vicente Felipo. (2021) Rifaximin Prevents T-Lymphocytes and Macrophages Infiltration in Cerebellum and Restores Motor Incoordination in Rats with Mild Liver Damage. Biomedicines 9:8, pages 1002.
Crossref
Crossref
Savan Kabaria, Ishita Dalal, Kapil Gupta, Abhishek Bhurwal, Minacapelli Carlos D., Carolyn Catalano & Vinod Rustgi. (2021) Hepatic Encephalopathy: A Review. EMJ Hepatology, pages 89-97.
Crossref
Crossref
P. Thomson, P. Núñez, R. Quera & C. Bay. (2021) Gastrointestinal microbiome, what is behind faecal microbiota transplantation?. New Microbes and New Infections 42, pages 100898.
Crossref
Crossref
Mattia Paratore, Francesco Santopaolo, Giovanni Cammarota, Maurizio Pompili, Antonio Gasbarrini & Francesca Romana Ponziani. (2021) Fecal Microbiota Transplantation in Patients with HBV Infection or Other Chronic Liver Diseases: Update on Current Knowledge and Future Perspectives. Journal of Clinical Medicine 10:12, pages 2605.
Crossref
Crossref
Helen Vidot & Nicholas A. Shackel. (2021) Nutritional Supplementation for Patients with Decompensated Cirrhosis. Current Hepatology Reports 20:2, pages 53-60.
Crossref
Crossref
Kenta Yamamoto, Takashi Honda, Takanori Ito, Yoji Ishizu, Teiji Kuzuya, Masanao Nakamura, Ryoji Miyahara, Hiroki Kawashima, Masatoshi Ishigami & Mitsuhiro Fujishiro. (2020) The relationship between oral‐origin bacteria in the fecal microbiome and albumin–bilirubin grade in patients with hepatitis C. Journal of Gastroenterology and Hepatology 36:3, pages 790-799.
Crossref
Crossref
E Afecto, A Ponte, S Fernandes, J Silva, C Gomes, J Correia & J Carvalho. (2021) Fecal microbiota transplantation in hepatic encephalopathy : a review of the current evidence and future perspectives. Acta Gastro Enterologica Belgica 84:1, pages 87-90.
Crossref
Crossref
Kristoffer Kjærgaard, Anne Catrine Daugaard Mikkelsen, Charlotte Wilhelmina Wernberg, Lea Ladegaard Grønkjær, Peter Lykke Eriksen, Malene Flensborg Damholdt, Rajeshwar Prosad Mookerjee, Hendrik Vilstrup, Mette Munk Lauridsen & Karen Louise Thomsen. (2021) Cognitive Dysfunction in Non-Alcoholic Fatty Liver Disease—Current Knowledge, Mechanisms and Perspectives. Journal of Clinical Medicine 10:4, pages 673.
Crossref
Crossref
Umair Iqbal, Ravirajsinh N. Jadeja, Harshit S. Khara & Sandeep Khurana. (2021) A Comprehensive Review Evaluating the Impact of Protein Source (Vegetarian vs. Meat Based) in Hepatic Encephalopathy. Nutrients 13:2, pages 370.
Crossref
Crossref
Veronika Rackayová, Emmanuelle Flatt, Olivier Braissant, Jocelyn Grosse, Daniela Capobianco, Paola Mastromarino, Matthew McMillin, Sharon DeMorrow, Valérie A. McLin & Cristina Cudalbu. (2021) Probiotics improve the neurometabolic profile of rats with chronic cholestatic liver disease. Scientific Reports 11:1.
Crossref
Crossref
Zefeng Chen, Jingsheng Ruan, Dinghua Li, Min Wang, Zhiwei Han, Wenxia Qiu & Guobin Wu. (2021) The Role of Intestinal Bacteria and Gut–Brain Axis in Hepatic Encephalopathy. Frontiers in Cellular and Infection Microbiology 10.
Crossref
Crossref
Ramzi Hassouneh & Jasmohan S. Bajaj. (2021) Gut Microbiota Modulation and Fecal Transplantation: An Overview on Innovative Strategies for Hepatic Encephalopathy Treatment. Journal of Clinical Medicine 10:2, pages 330.
Crossref
Crossref
Ricardo Correa BARBUTI, Leonardo Lucca SCHIAVON, Cláudia P OLIVEIRA, Mário Reis ALVARES-DA-SILVA, Lígia Yukie SASSAKI, Maria do Carmo F PASSOS, Alberto Queiroz FARIAS, Luisa Leite BARROS, Bruno Paes BARRETO, Gisela Bandeira de Melo Lins de ALBUQUERQUE, Amanda Mandarino ALVES, Tomás NAVARRO-RODRIGUEZ & Paulo Lisboa BITTENCOURT. (2020) GUT MICROBIOTA, PREBIOTICS, PROBIOTICS, AND SYNBIOTICS IN GASTROINTESTINAL AND LIVER DISEASES: PROCEEDINGS OF A JOINT MEETING OF THE BRAZILIAN SOCIETY OF HEPATOLOGY (SBH), BRAZILIAN NUCLEUS FOR THE STUDY OF HELICOBACTER PYLORI AND MICROBIOTA (NBEHPM), AND BRAZILIAN FEDERATION OF GASTROENTEROLOGY (FBG). Arquivos de Gastroenterologia 57:4, pages 381-398.
Crossref
Crossref
Chencheng Xie & Dina Halegoua-DeMarzio. (2020) The Role of Gut Microbiome-Targeted Therapy in Nonalcoholic Fatty Liver Disease. Current Hepatology Reports 19:4, pages 420-428.
Crossref
Crossref
Ruijuan Dong, Ming Bai, Jin Zhao, Di Wang, Xiaoxuan Ning & Shiren Sun. (2020) A Comparative Study of the Gut Microbiota Associated With Immunoglobulin a Nephropathy and Membranous Nephropathy. Frontiers in Cellular and Infection Microbiology 10.
Crossref
Crossref
Radislav Nakov, Jonathan P. Segal, Carlo R. Settanni, Stefano Bibbò, Antonio Gasbarrini, Giovanni Cammarota & Gianluca Ianiro. (2020) Microbiome: what intensivists should know. Minerva Anestesiologica 86:7.
Crossref
Crossref
Renata Rivera-Flores, Segundo Morán-Villota, Luisa Cervantes-Barragán, Constantino López-Macias & Misael Uribe. (2020) Manipulation of microbiota with probiotics as an alternative for treatment of hepatic encephalopathy. Nutrition 73, pages 110693.
Crossref
Crossref
Noah Y. Mahpour, Lauren Pioppo-Phelan, Mishal Reja, Augustine Tawadros & Vinod K. Rustgi. (2020) Pharmacologic Management of Hepatic Encephalopathy. Clinics in Liver Disease 24:2, pages 231-242.
Crossref
Crossref
Vanessa Weir & K. Rajender Reddy. (2020) Nonpharmacologic Management of Hepatic Encephalopathy. Clinics in Liver Disease 24:2, pages 243-261.
Crossref
Crossref
Jun Seok & Ki Tae Suk. (2020) Gut-microbiome Taxonomic Profiling as Non-invasive Biomarkers for the Early Detection of Alcoholic Hepatocellular Carcinoma. Journal of Liver Cancer 20:1, pages 32-40.
Crossref
Crossref
Susan S. Baker & Robert D. Baker. 2020. Gut Microbiota and Pathogenesis of Organ Injury. Gut Microbiota and Pathogenesis of Organ Injury
39
54
.
Cyriac Abby Philips, Philip Augustine, Praveen Kumar Yerol, Ganesh Narayan Ramesh, Rizwan Ahamed, Sasidharan Rajesh, Tom George & Sandeep Kumbar. (2019) Modulating the Intestinal Microbiota: Therapeutic Opportunities in Liver Disease. Journal of Clinical and Translational Hepatology X:X, pages 1-13.
Crossref
Crossref
Hiroyuki Suzuki, Hitomi Sezaki, Fumitaka Suzuki, Kayoko Kasuya, Tomoya Sano, Shunichiro Fujiyama, Yusuke Kawamura, Tetsuya Hosaka, Norio Akuta, Satoshi Saitoh, Masahiro Kobayashi, Yasuji Arase, Kenji Ikeda, Yoshiyuki Suzuki & Hiromitsu Kumada. (2019) Real‐world effects of long‐term rifaximin treatment for Japanese patients with hepatic encephalopathy. Hepatology Research 49:12, pages 1406-1413.
Crossref
Crossref
Carmen De Caro, Luigi Francesco Iannone, Rita Citraro, Pasquale Striano, Giovambattista De Sarro, Andrew Constanti, John F. Cryan & Emilio Russo. (2019) Can we ‘seize’ the gut microbiota to treat epilepsy?. Neuroscience & Biobehavioral Reviews 107, pages 750-764.
Crossref
Crossref
Martinsen, Fossmark & Waldum. (2019) The Phylogeny and Biological Function of Gastric Juice—Microbiological Consequences of Removing Gastric Acid. International Journal of Molecular Sciences 20:23, pages 6031.
Crossref
Crossref
Chencheng Xie & Dina Halegoua-DeMarzio. (2019) Role of Probiotics in Non-alcoholic Fatty Liver Disease: Does Gut Microbiota Matter?. Nutrients 11:11, pages 2837.
Crossref
Crossref
Ji Yao Wang, Jasmohan S. Bajaj, Jiang Bin Wang, Jia Shang, Xin Min Zhou, Xiao Lin Guo, Xuan Zhu, Li Na Meng, Hai Xing Jiang, Yu Qiang Mi, Jian Ming Xu, Jin Hui Yang, Bai Song Wang & Ning Ping Zhang. (2019) Lactulose improves cognition, quality of life, and gut microbiota in minimal hepatic encephalopathy: A multicenter, randomized controlled trial. Journal of Digestive Diseases 20:10, pages 547-556.
Crossref
Crossref
Xiao-Yuan Xu, Hui-Guo Ding, Wen-Gang Li, Ji-Dong Jia, Lai Wei, Zhong-Ping Duan, Yu-Lan Liu, En-Qiang Ling-Hu, Hui Zhuang, Chinese Society of Hepatology & Chinese Medical Association. (2019) Chinese guidelines on management of hepatic encephalopathy in cirrhosis. World Journal of Gastroenterology 25:36, pages 5403-5422.
Crossref
Crossref
Marica Meroni, Miriam Longo & Paola Dongiovanni. (2019) Alcohol or Gut Microbiota: Who Is the Guilty?. International Journal of Molecular Sciences 20:18, pages 4568.
Crossref
Crossref
Masafumi Haraguchi, Satoshi Miuma, Hiroshi Masumoto, Tatsuki Ichikawa, Yasuko Kanda, Ryu Sasaki, Masanori Fukushima, Hisamitsu Miyaaki, Naota Taura & Kazuhiko Nakao. (2019) Bacteroides in colonic mucosa-associated microbiota affects the development of minimal hepatic encephalopathy in patients with cirrhosis. Hepatology International 13:4, pages 482-489.
Crossref
Crossref
Daniela Campion, Ilaria Giovo, Paola Ponzo, Giorgio M Saracco, Federico Balzola & Carlo Alessandria. (2019) Dietary approach and gut microbiota modulation for chronic hepatic encephalopathy in cirrhosis. World Journal of Hepatology 11:6, pages 489-512.
Crossref
Crossref
Haripriya Gupta, Gi Soo Youn, Min Jea Shin & Ki Tae Suk. (2019) Role of Gut Microbiota in Hepatocarcinogenesis. Microorganisms 7:5, pages 121.
Crossref
Crossref
Radha K. Dhiman & Sahaj Rathi. 2019. Evidence‐based Gastroenterology and Hepatology 4e. Evidence‐based Gastroenterology and Hepatology 4e
676
692
.
Jasmohan S. Bajaj. (2019) Alcohol, liver disease and the gut microbiota. Nature Reviews Gastroenterology & Hepatology 16:4, pages 235-246.
Crossref
Crossref
Kenta Yamamoto, Masatoshi Ishigami, Takashi Honda, Tomoaki Takeyama, Takanori Ito, Yoji Ishizu, Teiji Kuzuya, Kazuhiko Hayashi, Hidemi Goto & Yoshiki Hirooka. (2019) Influence of proton pump inhibitors on microbiota in chronic liver disease patients. Hepatology International 13:2, pages 234-244.
Crossref
Crossref
Douglas S. Lewis, Tzu-Hao Lee, Meghana Konanur, Cole Ziegler, Melissa D. Hall, Waleska M. Pabon-Ramos, Paul V. Suhocki, Tony P. Smith, Charles Y. Kim, Steven S. Choi & James Ronald. (2019) Proton Pump Inhibitor Use Is Associated with an Increased Frequency of New or Worsening Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt Creation. Journal of Vascular and Interventional Radiology 30:2, pages 163-169.
Crossref
Crossref
Samuel Selorm Fiati Kenston, Xin Song, Zhou Li & Jinshun Zhao. (2018) Mechanistic insight, diagnosis, and treatment of ammonia‐induced hepatic encephalopathy. Journal of Gastroenterology and Hepatology 34:1, pages 31-39.
Crossref
Crossref
Chang Mu Sung, Yu-fei Lin, Kuan-Fu Chen, Huei-mien Ke, Hao-Yi Huang, Yu-Nong Gong, Wen-Sy Tsai, Jeng-Fu You, Meiyeh J. Lu, Hao-Tsai Cheng, Cheng-Yu Lin, Chia-Jung Kuo, Isheng J. Tsai & Sen-Yung Hsieh. (2019) Predicting Clinical Outcomes of Cirrhosis Patients With Hepatic Encephalopathy From the Fecal Microbiome. Cellular and Molecular Gastroenterology and Hepatology 8:2, pages 301-318.e2.
Crossref
Crossref
Aryashree Arunima, Jugal Kishore Das & Mrutyunjay Suar. 2019. Dietary Interventions in Gastrointestinal Diseases. Dietary Interventions in Gastrointestinal Diseases
117
131
.
Yating Li, Longxian Lv, Jianzhong Ye, Daiqiong Fang, Ding Shi, Wenrui Wu, Qing Wang, Jingjing Wu, Liya Yang, Xiaoyuan Bian, Xianwan Jiang, Huiyong Jiang, Ren Yan, Conggao Peng & Lanjuan Li. (2018) Bifidobacterium adolescentis CGMCC 15058 alleviates liver injury, enhances the intestinal barrier and modifies the gut microbiota in d-galactosamine-treated rats. Applied Microbiology and Biotechnology 103:1, pages 375-393.
Crossref
Crossref
Hui Fang, Fanpeng Meng, Fengyuan Piao, Bo Jin, Ming Li & Wenzhe Li. 2019. Taurine 11. Taurine 11
13
24
.
Eric Kallwitz & Zurabi Lominadze. 2019. Liver Disease. Liver Disease
179
193
.
Guang Ying Zhuo, Tao Xiang, Pei Yong Zhang, Xiao Dong Zhang, Li Luo, Ji Mei Zhang & Long Li Zhang. (2019) Effects of rifaximin versus nonabsorbable disaccharides in hepatic encephalopathy. GastroHep 1:1, pages 22-32.
Crossref
Crossref
Jonathan P. Jacobs, Tien S. Dong, Vatche Agopian, Venu Lagishetty, Vinay Sundaram, Mazen Noureddin, Walid S. Ayoub, Francisco Durazo, Jihane Benhammou, Pedram Enayati, David Elashoff, Marc T. Goodman, Joseph Pisegna & Shehnaz Hussain. (2018) Microbiome and bile acid profiles in duodenal aspirates from patients with liver cirrhosis: The Microbiome, Microbial Markers and Liver Disease Study. Hepatology Research 48:13, pages 1108-1117.
Crossref
Crossref
Wen-Rui Xie, Xiao-Ya Yang, Harry Hua-Xiang Xia & Xing-Xiang He. (2018) Fecal Microbiota Transplantation for Treating Hepatic Encephalopathy: Experimental and Clinical Evidence and Possible Underlying Mechanisms. Journal of Exploratory Research in Pharmacology 3:4, pages 105-110.
Crossref
Crossref
Timon E. Adolph, Christoph Grander, Alexander R. Moschen & Herbert Tilg. (2018) Liver–Microbiome Axis in Health and Disease. Trends in Immunology 39:9, pages 712-723.
Crossref
Crossref
Caio Pupin Rosa, Gustavo Andrade Brancaglion, Tatimara M. Miyauchi-Tavares, Patrícia Paiva Corsetti & Leonardo Augusto de Almeida. (2018) Antibiotic-induced dysbiosis effects on the murine gastrointestinal tract and their systemic repercussions. Life Sciences 207, pages 480-491.
Crossref
Crossref
Paul Carrier & Véronique Loustaud-Ratti. (2018) Treating hepatic encephalopathy in cirrhotic patients admitted to ICU with sodium phenylbutyrate: a preliminary study. Fundamental & Clinical Pharmacology 32:2, pages 206-208.
Crossref
Crossref
Brian C. Davis & Jasmohan S. Bajaj. (2018) Effects of Alcohol on the Brain in Cirrhosis: Beyond Hepatic Encephalopathy. Alcoholism: Clinical and Experimental Research 42:4, pages 660-667.
Crossref
Crossref
Li Zhang, Weida Wu, Yuan-Kun Lee, Jingjing Xie & Hongfu Zhang. (2018) Spatial Heterogeneity and Co-occurrence of Mucosal and Luminal Microbiome across Swine Intestinal Tract. Frontiers in Microbiology 9.
Crossref
Crossref
Steven L. Flamm, Kevin D. Mullen, Zeev Heimanson & Arun J. Sanyal. (2018) Rifaximin has the potential to prevent complications of cirrhosis. Therapeutic Advances in Gastroenterology 11, pages 175628481880030.
Crossref
Crossref
C. A. Woodhouse, V. C. Patel, A. Singanayagam & D. L. Shawcross. (2017) Review article: the gut microbiome as a therapeutic target in the pathogenesis and treatment of chronic liver disease. Alimentary Pharmacology & Therapeutics 47:2, pages 192-202.
Crossref
Crossref
Andrea Mancini, Francesca Campagna, Piero Amodio & Kieran M. Tuohy. (2018) Gut : liver : brain axis: the microbial challenge in the hepatic encephalopathy. Food & Function 9:3, pages 1373-1388.
Crossref
Crossref
Chao Tang, Jian Sun, Bo Zhou, Changhai Jin, Jun Liu, Juan Kan, Chunlu Qian & Nianfeng Zhang. (2018) Effects of polysaccharides from purple sweet potatoes on immune response and gut microbiota composition in normal and cyclophosphamide treated mice. Food & Function 9:2, pages 937-950.
Crossref
Crossref
Kavish R. Patidar & Jasmohan Singh Bajaj. 2018. Zakim and Boyer's Hepatology. Zakim and Boyer's Hepatology
203
219.e6
.
Kosuke Kaji, Hiroaki Takaya, Soichiro Saikawa, Masanori Furukawa, Shinya Sato, Hideto Kawaratani, Mitsuteru Kitade, Kei Moriya, Tadashi Namisaki, Takemi Akahane, Akira Mitoro & Hitoshi Yoshiji. (2017) Rifaximin ameliorates hepatic encephalopathy and endotoxemia without affecting the gut microbiome diversity. World Journal of Gastroenterology 23:47, pages 8355-8366.
Crossref
Crossref
Aditya Narayan Sarangi, Amit Goel, Ankur Singh, Avani Sasi & Rakesh Aggarwal. (2017) Faecal bacterial microbiota in patients with cirrhosis and the effect of lactulose administration. BMC Gastroenterology 17:1.
Crossref
Crossref
Puneeta Tandon, Karen Madsen & Dina Kao. (2017) Fecal microbiota transplantation for hepatic encephalopathy: Ready for prime time?. Hepatology 66:6, pages 1713-1715.
Crossref
Crossref
Chathur Acharya & Jasmohan S. Bajaj. 2017. Schiff's Diseases of the Liver. Schiff's Diseases of the Liver
387
410
.
Marwan Ghabril, Mollie Jackson, Raghavender Gotur, Regina Weber, Eric Orman, Raj Vuppalanchi & Naga Chalasani. (2017) Most Individuals With Advanced Cirrhosis Have Sleep Disturbances, Which Are Associated With Poor Quality of Life. Clinical Gastroenterology and Hepatology 15:8, pages 1271-1278.e6.
Crossref
Crossref
Chia-Fen Tsai, Mu-Hong Chen, Yen-Po Wang & Ching-Liang Lu. (2017) Reply. Gastroenterology 152:8, pages 2077-2078.
Crossref
Crossref
Peter Ferenci. (2017) Hepatic encephalopathy. Gastroenterology Report 5:2, pages 138-147.
Crossref
Crossref
Georgios D Kitsios, Michael J Morowitz, Robert P Dickson, Gary B. Huffnagle, Bryan J McVerry & Alison Morris. (2017) Dysbiosis in the intensive care unit: Microbiome science coming to the bedside. Journal of Critical Care 38, pages 84-91.
Crossref
Crossref
Mark J. W. McPhail, Sara Montagnese, Manuela Villanova, Hamza El Hadi, Piero Amodio, Mary M. E. Crossey, Roger Williams, I. Jane Cox & Simon D. Taylor-Robinson. (2016) Urinary metabolic profiling by 1H NMR spectroscopy in patients with cirrhosis may discriminate overt but not covert hepatic encephalopathy. Metabolic Brain Disease 32:2, pages 331-341.
Crossref
Crossref
Cicely Proctor, Parameth Thiennimitr, Nipon Chattipakorn & Siriporn C Chattipakorn. (2016) Diet, gut microbiota and cognition. Metabolic Brain Disease 32:1, pages 1-17.
Crossref
Crossref
Chia-Fen Tsai, Mu-Hong Chen, Yen-Po Wang, Chi-Jen Chu, Yi-Hsiang Huang, Han-Chieh Lin, Ming-Chih Hou, Fa-Yauh Lee, Tung-Ping Su & Ching-Liang Lu. (2017) Proton Pump Inhibitors Increase Risk for Hepatic Encephalopathy in Patients With Cirrhosis in A Population Study. Gastroenterology 152:1, pages 134-141.
Crossref
Crossref
Barjesh Chander Sharma & Jatinderpal Singh. (2016) Probiotics in management of hepatic encephalopathy. Metabolic Brain Disease 31:6, pages 1295-1301.
Crossref
Crossref
Vishal C. Patel, Helen White, Sidsel Støy, Jasmohan S. Bajaj & Debbie L. Shawcross. (2015) Clinical science workshop: targeting the gut-liver-brain axis. Metabolic Brain Disease 31:6, pages 1327-1337.
Crossref
Crossref
Manuela Merli, Valerio Iebba & Michela Giusto. (2015) What is new about diet in hepatic encephalopathy. Metabolic Brain Disease 31:6, pages 1289-1294.
Crossref
Crossref
Abidullah Khan, Maimoona Ayub & Wazir Mohammad Khan. (2016) Hyperammonemia Is Associated with Increasing Severity of Both Liver Cirrhosis and Hepatic Encephalopathy. International Journal of Hepatology 2016, pages 1-5.
Crossref
Crossref
Rasha Abdel-Ghany, Ebaa Mohammed, Shimaa Anis & Waleed Barakat. (2016) Impact of Exposure to Fenitrothion on Vital Organs in Rats. Journal of Toxicology 2016, pages 1-18.
Crossref
Crossref
Jasmohan S. Bajaj. 2016. Portal Hypertension VI. Portal Hypertension VI
169
184
.
Sahar El Aidy, Roman Stilling, Timothy G. Dinan & John F. Cryan. 2016. Microbial Endocrinology: Interkingdom Signaling in Infectious Disease and Health. Microbial Endocrinology: Interkingdom Signaling in Infectious Disease and Health
301
336
.
Dina Kao, Brandi Roach, Heekuk Park, Naomi Hotte, Karen Madsen, Vince Bain & Puneeta Tandon. (2015) Fecal microbiota transplantation in the management of hepatic encephalopathy. Hepatology 63:1, pages 339-340.
Crossref
Crossref
Li-Na Zhao, Tao Yu, Shao-Yang Lan, Jiang-Tao Hou, Zheng-Zheng Zhang, Shuang-Shuang Wang & Feng-Bin Liu. (2015) Probiotics can improve the clinical outcomes of hepatic encephalopathy: An update meta-analysis. Clinics and Research in Hepatology and Gastroenterology 39:6, pages 674-682.
Crossref
Crossref
Kavish R. Patidar & Jasmohan S. Bajaj. (2015) Covert and Overt Hepatic Encephalopathy: Diagnosis and Management. Clinical Gastroenterology and Hepatology 13:12, pages 2048-2061.
Crossref
Crossref
K.R. Magnusson, L. Hauck, B.M. Jeffrey, V. Elias, A. Humphrey, R. Nath, A. Perrone & L.E. Bermudez. (2015) Relationships between diet-related changes in the gut microbiome and cognitive flexibility. Neuroscience 300, pages 128-140.
Crossref
Crossref
Norman L. Sussman. (2015) Treatment of Overt Hepatic Encephalopathy. Clinics in Liver Disease 19:3, pages 551-563.
Crossref
Crossref
Jasmohan S. Bajaj. (2015) Microbiome and complications of liver disease. Clinical Liver Disease 5:4, pages 96-99.
Crossref
Crossref
Yun Yan Su, Gui Fen Yang, Guang Ming Lu, Shawn Wu & Long Jiang Zhang. (2014) PET and MR imaging of neuroinflammation in hepatic encephalopathy. Metabolic Brain Disease 30:1, pages 31-45.
Crossref
Crossref
Xuemei Tao, Ning Wang & Wenxin Qin. (2015) Gut Microbiota and Hepatocellular Carcinoma. Gastrointestinal Tumors 2:1, pages 33-40.
Crossref
Crossref
David W. Victor3rd3rd & Eamonn M.M. Quigley. (2014) Microbial Therapy in Liver Disease: Probiotics Probe the Microbiome–Gut–Liver–Brain Axis. Gastroenterology 147:6, pages 1216-1218.
Crossref
Crossref
Cinzia Signorini, Claudio De Felice, Silvia Leoncini, Thierry Durand, Jean-Marie Galano, Alessio Cortelazzo, Gloria Zollo, Roberto Guerranti, Stefano Gonnelli, Carla Caffarelli, Marcello Rossi, Alessandra Pecorelli, Giuseppe Valacchi, Lucia Ciccoli & Joussef Hayek. (2014) Altered erythrocyte membrane fatty acid profile in typical Rett syndrome: Effects of omega-3 polyunsaturated fatty acid supplementation. Prostaglandins, Leukotrienes and Essential Fatty Acids 91:5, pages 183-193.
Crossref
Crossref
Federica Del Chierico, Pamela Vernocchi, Bruno Dallapiccola & Lorenza Putignani. (2014) Mediterranean Diet and Health: Food Effects on Gut Microbiota and Disease Control. International Journal of Molecular Sciences 15:7, pages 11678-11699.
Crossref
Crossref